Login / Signup

Primary intraventricular hemorrhage outcomes in the CLEAR III trial.

Sarah E NelsonW Andrew MouldDheeraj GandhiRichard E ThompsonSarah SalterRachel DlugashIssam A AwadDaniel F HanleyWendy Ziai
Published in: International journal of stroke : official journal of the International Stroke Society (2020)
In CLEAR III, primary intraventricular hemorrhage patients who survived achieved better long-term outcomes than surviving secondary intraventricular hemorrhage patients with similar mortality. Outcomes and safety were similar between primary intraventricular hemorrhage patients receiving alteplase and those receiving saline.
Keyphrases
  • clinical trial
  • study protocol
  • cardiovascular events
  • type diabetes
  • randomized controlled trial
  • risk factors
  • phase iii
  • coronary artery disease
  • metabolic syndrome
  • acute ischemic stroke